Identifying and Treating Progression in MS Beyond Relapses: Celia Oreja-Guevara, MD, PhD

The vice chair of neurology at the Hospital Clínico San Carlos in Madrid highlighted the growing importance of detecting and managing progression in multiple sclerosis, particularly PIRA. [WATCH TIME: 6 minutes]:

Source: Neurology Read More

Previous PostPregnancy Outcomes in Ofatumumab-Treated Women Appear Consistent With General Population Rates
Next PostWhy Choose a DORA? Clinical Considerations for Patients With Insomnia

Identifying and Treating Progression in MS Beyond Relapses: Celia Oreja-Guevara, MD, PhD

Previous PostPregnancy Outcomes in Ofatumumab-Treated Women Appear Consistent With General Population Rates

Next PostWhy Choose a DORA? Clinical Considerations for Patients With Insomnia

Related Posts

<![CDATA[TEMPO-4 Extension Analysis: Tavapadon Shows Levodopa-Sparing Potential in Parkinson Disease]]>

<![CDATA[Telitacicept Moves Forward in Global Phase 3 Study for Generalized Myasthenia Gravis]]>

<![CDATA[Once-Daily Alixorexton Improves Cognition, Fatigue, and Disease Severity in Phase 2 Narcolepsy Type 1 Study]]>

Categories